MISSISSAUGA, Ontario (AP) _ Trillium Therapeutics Inc. (TRIL) on Friday reported a loss of $19.3 million in its third quarter.

On a per-share basis, the Mississauga, Ontario-based company said it had a loss of 18 cents.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TRIL at https://www.zacks.com/ap/TRIL

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News